Concepedia

Vivek Durai

VD

Statistics

Publications

20

Citations

2.8K

H-Index

18

Active since

2010

Affiliations

Washington University in St. Louis(Current)

Howard Hughes Medical Institute

University of Münster

Stanford University

Jewish Hospital

Vivek Durai is an author at Washington University in St. Louis specializing in life sciences, immunology, and dendritic cell biology.

ORCID

Publications per year

2010–2023

20

Publications

20

cDC1 prime and are licensed by CD4+ T cells to induce anti-tumour immunity

Stephen T. Ferris, Vivek Durai, Renee Wu et al. · Nature · 2020 · 587 citations · Full text

, , +14

Batf3 maintains autoactivation of Irf8 for commitment of a CD8α+ conventional DC clonogenic progenitor

Gary E. Grajales‐Reyes, Arifumi Iwata, Jörn C. Albring et al. · Nature Immunology · 2015 · 393 citations · Full text

, , +7

WDFY4 is required for cross-presentation in response to viral and tumor antigens

Derek J. Theisen, Jesse T. Davidson, Carlos G. Briseño et al. · Science · 2018 · 339 citations · Full text

, , +14

Distinct Transcriptional Programs Control Cross-Priming in Classical and Monocyte-Derived Dendritic Cells

Carlos G. Briseño, Malay Haldar, Nicole M. Kretzer et al. · Cell Reports · 2016 · 208 citations · Full text

, , +15

Cryptic activation of an Irf8 enhancer governs cDC1 fate specification

Vivek Durai, Prachi Bagadia, Jeffrey M. Granja et al. · Nature Immunology · 2019 · 168 citations · Full text

, , +11

1–5 of 20